Pine Pharmaceuticals, LLC is voluntarily recalling 30,663 units of various compounded injectable and ophthalmic drugs, including Bevacizumab, Vancomycin, and Lidocaine. The recall was initiated due to a lack of assurance of sterility, meaning the medications may not be completely free of microorganisms. These products were distributed nationwide in the United States to healthcare providers, healthcare facilities, and specialty pharmacies. No injuries or illnesses have been reported to date.
Using medications that are not sterile can cause serious, life-threatening infections. For drugs injected into the eye, this can result in permanent vision loss, while intravenous injections can lead to systemic infections or sepsis.
Healthcare facility administered drug return.
Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
Rx only
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.